dc.contributor.author |
Aimé, Ahissan |
|
dc.contributor.author |
Beztsinna, Nataliia |
|
dc.contributor.author |
Patwa, Amit |
|
dc.contributor.author |
Pokolenko, Alexander |
|
dc.contributor.author |
Bestel, Isabelle |
|
dc.contributor.author |
Barthélémy, Philippe |
|
dc.date.accessioned |
2019-06-14T05:00:52Z |
|
dc.date.available |
2019-06-14T05:00:52Z |
|
dc.date.issued |
2013-07-26 |
|
dc.identifier.issn |
1043-1802 (P-ISSN) |
|
dc.identifier.issn |
1520-4812 (E-ISSN) |
|
dc.identifier.uri |
http://27.109.7.66:8080/xmlui/handle/123456789/580 |
|
dc.description |
Bioconjugate Chemistry, Vol-24, Issue-8, 2013, p. 1345-1355 |
en_US |
dc.description.abstract |
The construction of new nanotools is presented here using the example of fluorescent semiconductor nanocrystals, quantum dots (QDs). In this study, the implementation
of the new lipid oligonucleotide conjugate-functionalized quantum dots (LON-QDs) is realized in four steps: (i) the synthesis of the lipid oligonucleotide conjugates (LONs), (ii)
the encapsulation of QDs by nucleolipids and LONs, (iii) the study of the duplex formation of LON-QDs with the complementary ON partners, and (iv) the cellular uptake of
the LON-QD platform and hybridization with the target ONs (microRNA and miR-21). |
en_US |
dc.language.iso |
en_US |
en_US |
dc.publisher |
American Chemical Society |
en_US |
dc.subject |
Quantum dots |
en_US |
dc.subject |
Bioconjugates |
en_US |
dc.subject |
Lipid-oligonucleotide |
en_US |
dc.subject |
Self-assembly |
en_US |
dc.subject |
Surface plasmon resonance |
en_US |
dc.title |
Quantum dot lipid oligonucleotide bioconjugates: toward a new anti-microrna nanoplatform |
en_US |
dc.type |
Article |
en_US |